Pharmacovigilance Analytics

Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring

Jose Rossello — Sun, 07 Apr 2024 05:11:12 +0000

Pharmacovigilance plays a crucial role in ensuring public safety by monitoring, identifying, and assessing potential drug-related risks and adverse events after market authorization. With the rapid expansion of available health data and evolving needs of the pharmaceutical industry, there is a growing demand for advanced techniques to manage, analyze, and interpret this data to improve safety […]

The post Signal Analytics Technology in Pharmacovigilance: Enhancing Drug Safety Monitoring appeared first on Pharmacovigilance Analytics.

8 Common FDA Applications for Drugs & Biologics

Jose Rossello — Mon, 08 Jan 2024 02:15:16 +0000

The U.S. Food and Drug Administration (FDA) has several types of applications for the approval of drugs and biologics. These applications are part of the regulatory process that ensures the safety, efficacy, and quality of new medicinal products. Here’s an overview of the different types of FDA applications: Each type of application has its specific […]

The post 8 Common FDA Applications for Drugs & Biologics appeared first on Pharmacovigilance Analytics.

Key IND Enabling Studies: Navigating Preclinical Development Regulations

Jose Rossello — Mon, 08 Jan 2024 02:07:19 +0000

Investigational New Drug (IND) applications represent a critical stage in the development of new pharmaceuticals and biologics. Before a new drug can be administered to humans in clinical trials, the U.S. Food and Drug Administration (FDA) requires substantial evidence that it is safe and potentially effective. This is where IND-enabling studies play a pivotal role, […]

The post Key IND Enabling Studies: Navigating Preclinical Development Regulations appeared first on Pharmacovigilance Analytics.

Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness

Jose Rossello — Sun, 07 Jan 2024 23:09:58 +0000

Pharmacokinetics and pharmacodynamics are two fundamental pillars in the field of pharmaceutical sciences that dictate how drugs interact with the body and vice versa. Pharmacokinetics (PK) describes the movement of drugs through the body over time, encompassing processes of absorption, distribution, metabolism, and excretion. These actions determine the concentration of drugs within various tissues and […]

The post Pharmacokinetics and Pharmacodynamics (PKPD): Fundamentals in Drug Development and Therapeutic Effectiveness appeared first on Pharmacovigilance Analytics.

Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates

Jose Rossello — Fri, 29 Dec 2023 06:27:06 +0000

Regulatory authorities in the pharmaceutical industry have established standards regarding the management and reporting of safety information, particularly Reference Safety Information (RSI). RSI plays a crucial role in maintaining safety in clinical trials by providing a baseline for assessing suspected adverse reactions. Adhering to current regulations on RSI enables organizations to conduct efficient trials, minimizing risks for […]

The post Current Regulations Regarding Reference Safety Information (RSI): Key Aspects and Updates appeared first on Pharmacovigilance Analytics.

Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches

Jose Rossello — Thu, 28 Dec 2023 06:01:31 +0000

In the realm of patient safety and pharmacovigilance, statistical signal detection is a pivotal process that involves identifying potential adverse drug reactions (ADRs) from vast data sets of medication use. Pharmacovigilance is crucial for ensuring drug safety by systematically monitoring pharmaceutical products’ performance, detecting new evidence of hazards or changes in the benefit-risk balance of […]

The post Methods of Statistical Signal Detection in Patient Safety and Pharmacovigilance: Key Techniques and Approaches appeared first on Pharmacovigilance Analytics.

Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring

Jose Rossello — Thu, 28 Dec 2023 03:43:17 +0000

Pharmacovigilance signal detection software plays a crucial role in ensuring drug safety and monitoring potential adverse events associated with pharmaceutical products. The primary goal of pharmacovigilance is to protect public health by identifying, evaluating, and preventing undesired effects of these products. Signal detection is a core component of this process, as it enables the identification of new safety concerns […]

The post Pharmacovigilance Signal Detection Software: Enhancing Drug Safety and Monitoring appeared first on Pharmacovigilance Analytics.

What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports

Jose Rossello — Wed, 27 Dec 2023 20:48:47 +0000

A Periodic Benefit-Risk Evaluation Report (PBRER) serves as a structured framework for assessing the risks and benefits of a pharmaceutical product throughout its lifecycle. This document is critical for regulatory authorities, healthcare professionals, and pharmaceutical companies, as it ensures the ongoing evaluation of a product’s safety profile relative to its therapeutic effects after it has […]

The post What is a PBRER? Understanding Periodic Benefit-Risk Evaluation Reports appeared first on Pharmacovigilance Analytics.

Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences

Jose Rossello — Wed, 27 Dec 2023 07:43:41 +0000

Drug safety and pharmacovigilance are crucial aspects of public health, ensuring the safety and efficacy of medicines for patients. Drug safety focuses on monitoring and mitigating the potential risks and adverse effects of medications, while pharmacovigilance is a broader discipline that encompasses the collection, analysis, and evaluation of safety information related to drugs throughout their life cycle. […]

The post Drug Safety vs Pharmacovigilance: Exploring Conceptual Differences appeared first on Pharmacovigilance Analytics.

Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained

Jose Rossello — Wed, 27 Dec 2023 05:47:16 +0000

he Development Safety Update Report (DSUR) is a crucial document that serves as an annual safety report for drugs under development. Its primary purpose is to provide a comprehensive update on the safety profile of a drug, encompassing both clinical and non-clinical information gathered during a reporting period. Healthcare authorities require the DSUR to support […]

The post Which Sections of a DSUR Must Present Safety and Pharmacovigilance Quantitative Data: Key Components Explained appeared first on Pharmacovigilance Analytics.